All News Stories

Nvidia Sinks Despite Stellar Earnings; Top Analyst Says Buy On Any Weakness

Nvidia (NVDA) has posted stellar earning results for the fiscal first quarter, although shares moved marginally lower in Thursday’s after-hours trading due to weaker-than-expected guidance. Income doubled from the same period last year, with Q1 Non-GAAP EPS of $1.80 beating the Street by $0.12, and GAAP EPS of $1.47 also topping expectations by $0.10.Revenue of $3.08B represented…

Goldman Says Buy World’s Worst Stock Market Because Rebound Is Coming

(Bloomberg) — Goldman Sachs is bullish on the world’s hardest-hit stock market.Down more than 48% this year when measured in dollars, Brazilian stocks will benefit from growing appetite for risky assets and a recovery in commodities prices during the second half of 2020, strategists led by Kamakshya Trivedi wrote in a report dated May 20.“Brazilian…

Moderna Stock Volatile Amid Work on Coronavirus Vaccine

Moderna, Inc. (NASDAQ:MRNA) stock popped after positive news about the company's coronavirus vaccine candidate. After the shares climbed 20% to record highs, the company announced plans to sell $1.25 billion in new shares to fund manufacturing and distribution of its vaccine candidate. Update on Moderna's coronavirus vaccine Moderna's coronavirus vaccine is officially referred to as…

Stocks Fall After Moderna Vaccine Study Questioned: Markets Wrap

(Bloomberg) — U.S. stocks fell for the first time in four sessions after reports circulated that Moderna Inc.’s vaccine study, which was credited in part for Monday’s rally, didn’t produce enough critical data to assess its success. Crude oil and Treasuries gained.The S&P 500 and Nasdaq Composite turned negative in the last hour of trading,…